Flaps, both pedicled and free, are essential tools in reconstructive surgery for addressing defects from injury, tumor excision, ulcers, or congenital malformations. However, a significant challenge is flap failure, primarily due to ischemic necrosis, affecting 5-10% of free flap patients. This guide will delve into the Flap Pathophysiology and Pharmacology behind these failures and explore current and future strategies for prevention and treatment, crucial knowledge for students of medicine and surgery.
Flap failure leads to substantial costs, prolonged hospitalization, and increased donor site morbidity, highlighting the critical need to understand its mechanisms. By examining the underlying pathophysiology, we can develop more effective pharmacological therapies to prevent or salvage compromised flaps.
Understanding Flap Failure: Pathophysiology and Mechanisms
When a flap fails, it's often due to insufficient blood supply leading to tissue death (ischemic necrosis). This process is complex, involving several interconnected mechanisms.
Vasospasm and Thrombosis: Key Pathogenic Factors
Ischemic necrosis typically occurs in the distal parts of both pedicled and free flaps. The primary culprits are vasospasm (narrowing of blood vessels) and thrombosis (blood clot formation), often triggered by surgical trauma and inadequate distal vascularity.
Under normal physiological conditions, a delicate balance exists between endothelium-derived relaxing factors (EDRFs) like prostacyclin (PGI2) and nitric oxide (NO), which relax blood vessels and inhibit platelet aggregation, and endothelium-derived contracting factors (EDCFs) like thromboxane A2 (TXA2) and endothelin-1 (ET-1), which increase vascular tone. Surgical trauma disrupts this balance: - Traumatized sympathetic nerve endings release norepinephrine (NE), causing vasoconstriction and platelet aggregation. - Platelets release leukotrienes, serotonin (5HT2), and TXA2. - Traumatized vascular endothelial cells release ET-1. These substances concentrate in the distal flap, exacerbating vasospasm and promoting thrombosis. Hemoglobin from hematomas also acts as a potent vasoconstrictor, and histamine from mast cells can cause edema. Furthermore, the synthesis of EDRFs is depressed, and the degradation of vasoconstrictors like NE and 5HT2 is reduced, creating a local environment ripe for flap failure.
Ischemia-Reperfusion Injury: The Xanthine Oxidase System and Neutrophil Involvement
Free flap surgery involves a period of warm ischemia when the flap is transferred, followed by reperfusion. Excessive ischemia can lead to ischemia-reperfusion injury, characterized by energy depletion and the formation of harmful oxygen-derived free radicals.
During prolonged ischemia, ATP breaks down into hypoxanthine, and intracellular Ca2+ levels rise, activating a protease that converts xanthine dehydrogenase to xanthine oxidase. Upon reperfusion, xanthine oxidase generates superoxide (O2•), which then forms hydrogen peroxide (H2O2) and the highly cytotoxic hydroxyl radical (OH•). This hypoxanthine/xanthine oxidase system is a major source of oxyradicals in ischemic rat skin and muscle. However, its role in pigs and humans is less pronounced, with significantly lower xanthine oxidase activity.
Neutrophils also play a critical role in ischemia-reperfusion injury, particularly in free flap surgery. Activated neutrophils produce large amounts of O2• via NADPH oxidase, which then generates H2O2 and OH•, causing tissue damage. Myeloperoxidase (MPO), abundant in neutrophils, converts H2O2 into hypochlorous acid (HOCl), a potent oxidizing agent. Evidence suggests that blocking neutrophil adhesion or depleting neutrophils can reduce ischemia-reperfusion-induced necrosis and vasoconstriction. However, some studies argue against the sole importance of neutrophils, as injury can occur in neutrophil-free systems.
Intracellular Calcium Overload: A Pathway to Cell Death
Recent research highlights the crucial role of intracellular Ca2+ overload in causing cell death during ischemia-reperfusion injury.
During sustained ischemia, ATP synthesis stops, leading to anaerobic glycolysis, lactate accumulation, and intracellular acidosis. This activates the Na+/H+ exchanger isoform-1 (NHE-1), extruding H+ and accumulating intracellular Na+. Elevated intracellular Na+ then activates the Na+/Ca2+ exchanger, causing Ca2+ influx and leading to intracellular Ca2+ overload.
This overload culminates in mitochondrial Ca2+ overload, which depolarizes mitochondria, impairs ATP synthesis, and ultimately results in cell necrosis. Reperfusion can exacerbate this by reactivating NHE-1, further increasing intracellular Na+ and Ca2+ overload.
No-Reflow Phenomenon in Free Flap Surgery
The